Browsing by Subject "Coronary heart disease"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Publication
    Open Access
    Enhanced accumulation of the isoprostane, 8-epi-PGF2a, in human aortic and pulmonary valves of patients with coronary heart disease
    (Murcia : F. Hernández, 2002) Mehrabi, M.R.; Serbecic, N.; Ekmekcioglu, C.; Tamaddon, F.; Wild, T.; Plesch, K.; Sinzinger, H.; Glogar, H.D.
    The aim of the present study was to investigate whether the isoprostane 8-epi-PGF2a differently accumulates in semilunar valves of patients suffering from coronary heart disease (CHD, n=19) as compared to valves from healthy heart donors (controls, n=6). Sections from isolated aortic and pulmonary valves were analyzed by semiquantitative immunohistochemistry. The 8-epi-PGF2a-content was determined by using a specific radioimmunoassay. The accumulation of 8-epi-PGF2a in both valves was higher in CHD-patients in comparison to controls (Aortic valves: 36.49±11.26 % vs. 15.78±3.04 %; pulmonary valves: 46.79±9.80 % vs. 14.99±3.57 %). The results from the radioimmunoassay revealed comparable findings in both groups (CHD vs. controls: 395.95±86.09 vs. 139.50±47.46 pg/mg protein in the aortic valves and 430.47±76.30 vs. 147.33±53.84 pg/mg protein in pulmonary valves). Pulmonary valves seem to be more susceptible to oxidative stress than aortic valves as evidenced by a higher accumulation of 8-epi-PGF2a in CHD patients. Considering the data presented in this study, we suggest that 8-epi-PGF2a is a valuable indicator of oxidative injury in human semilunar valve